← SynDRA
CC-115
SynDRA canonical compound SYN0038324 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MTOR |
|---|
| Mechanism of action | DNA protein kinase inhibitor | mTOR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MTOR inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
- PRKDC INHIBITOR
- DNA-dependent protein kinase inhibitor
- DNA protein kinase inhibitor
Cross-references
Synonyms
- CC-115 (hydrochloride)
- CC-115 hydrochloride
- SCHEMBL1767621
- BCP20709
- HY-16962A
- AKOS030526389
- FII75TFH5L
- RefChem:124079
- DNA-PK/TOR Kinase Inhibitor CC-115
- CC115
- MFCD29036965
- GMYLVKUGJMYTFB-UHFFFAOYSA-N
- UNII-FII75TFH5L
- SCHEMBL135765
- orb1304086
- CC-115 [WHO-DD]
- SCHEMBL14877034
- SCHEMBL15995973
- SCHEMBL29354401
- SCHEMBL29522125
- SCHEMBL29702825
- SCHEMBL29808653
- SCHEMBL31683729
- C16H16N8O
- GLXC-07508
- GLXC-23037
- DZB01315
- EX-A3190
- BDBM50093082
- NSC793151
- s7891
- AKOS030526334
- CC-115?
- CCG-267869
- CS-4561
- NSC-793151
- SB19164
- NCGC00522580-02
Look up CC-115 in the interactive SynDRA portal →